Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity
HIT
Does a Family History of Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity in a Hispanic Population?
1 other identifier
interventional
24
1 country
1
Brief Summary
This study investigates weather a family history of type 2 diabetes affects exercise induced improvements in insulin sensitivity in the hispanic population
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 18, 2016
CompletedFirst Posted
Study publicly available on registry
April 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedJanuary 30, 2020
January 1, 2020
3.1 years
April 18, 2016
January 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Insulin sensitivity
8 weeks
Secondary Outcomes (1)
Myokine concentrations
8 weeks
Study Arms (2)
Family history of T2D
EXPERIMENTALThe participants will undergo 8 weeks of combined exercise
No Family history of T2D
EXPERIMENTALThe participants will undergo 8 weeks of combined exercise
Interventions
The subjects will undergo an 8 week combined exercise intervention
Eligibility Criteria
You may qualify if:
- ≤ Age ≤ 40 years
- ≤ BMI ≤ 30 kg/m2
- Both parents are Mexican/Mexican-American)
- Sedentary lifestyle
- Less than 60 minutes/wk. of structured exercise
- Physical activity level ≤ 1.4
You may not qualify if:
- Evidence of significant cardiovascular disease or diabetes
- A fasting blood glucose ≥100 mg/dL
- Screening blood pressure \>140/90
- Hyperlipidemia
- Use of drugs affecting energy metabolism or body weight
- Excess alcohol, drug abuse, and smoking
- Eating disorder or eating attitudes interfering with study
- Unwillingness to be abide by randomization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas at El Paso
El Paso, Texas, 79968, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sudip Bajpeyi, PhD.
University of Texas, El Paso
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 18, 2016
First Posted
April 20, 2016
Study Start
April 1, 2016
Primary Completion
May 1, 2019
Study Completion
May 1, 2019
Last Updated
January 30, 2020
Record last verified: 2020-01